ArticleBreast cancer research : BCR2025

Prognostic value of FDG PET/CT in de novo stage IV breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors.

Wonseok Whi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.